Presence of functional cannabinoid receptors in human endocrine pancreas

Diabetologia

Volumn 51, Issue 3, 2008, Pages 476-487

  Bermudez Silva F J ^a   Suarez J ^a   Baixeras, E ^a   Cobo, N ^a   Bautista, D ^a   Cuesta Munoz A L ^a   Fuentes, E ^b   Juan Pico, P ^b   Castro, M J ^a   Milman, G ^c   Mechoulam, R ^c   Nadal, A ^b   Rodriguez De Fonseca F ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

2 Arachidonoylglycerol; Anandamide; Beta cell; Cannabinoid receptors; Fatty acid amidohydrolase; Glucagon; Human; Insulin; Islets of Langerhans; Somatostatin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; AMIDASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; LIPOPROTEIN LIPASE; PHOSPHOLIPASE D;

ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; GENE EXPRESSION; GLUCAGON RELEASE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INSULIN RELEASE; PANCREAS ISLET; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOMATOSTATIN RELEASE; WESTERN BLOTTING;

BRAIN DEATH; CANNABINOIDS; CEREBELLUM; GLUCAGON; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LEUKOCYTES; POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; SOMATOSTATIN-SECRETING CELLS; SYNAPTIC TRANSMISSION;

EID: 39049091518     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0890-y     Document Type: Article

References (41)

1. Devane WA, Dysarz FA 3rd, Johnson M, Melvin LS, Howlett AC (1998) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613
2. Devane WA, Hanus L, Breuer A et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
3. Stella N, Schweitzer P, Piomelli D (1992) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778
4. Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
5. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884
6. Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8:585-589
7. Cota D, Marsicano G, Tschop M et al (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431
8. Gomez R, Navarro M, Ferrer B et al (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612-9617
9. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557
10. Di Marzo V, Goparaju SK, Wang L et al (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825
11. Pavon FJ, Bilbao A, Hernandez-Folgado L et al (2006) Antiobesity effects of the novel in vivo neutral cannabinoid receptor Antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21. Neuropharmacology 51:358-366
12. Osei-Hyiaman D, DePetrillo M, Pacher P et al (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115:1298-1305
13. Engeli S, Bohnke J, Feldpausch M et al (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54:2838-2843
14. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, RIO-Europe Study Group (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365:1389-1397
15. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761-775
16. Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF, RIO-Diabetes Study Group (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 368:1660-1672
17. Juan-Pico P, Fuentes E, Bermúdez-Silva FJ et al (2006) Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cells. Cell Calcium 39:155-162
18. Bermudez-Silva FJ, Serrano A, Diaz-Molina FJ et al (2006) Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 531:282-284
19. 2 receptors in glucose homeostasis in rats. Eur J Pharmacol 565:207-211
20. Matias I, Gonthier MP, Orlando P et al (2006) Regulation, function and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrin Metab 91:3171-3180
21. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW (1988) Automated method for isolation of human pancreatic islets. Diabetes 37:413-420
22. Cuesta-Munoz AL, Briones RM, Mellado-Gil JM et al (2005) Internal assessment of a novel islet isolation facility in Spain. Transplant Proc 37:3404-3406
23. Hansson AC, Bermudez-Silva FJ, Malinen H et al (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117-126
24. Hillard CJ, Manna S, Greenberg MJ et al (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp The 289:1427-1433
25. Huffman JW, Liddle J, Yu S et al (1999) 3-(1′,1′- Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem 7:2905-2914
26. Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61:PL191-PL197
27. Pettit DAD, Harrison MP, Olson JM et al (1998) Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Methods 51:391-402
28. Egertová M, Elphick MR (2000) Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J Comp Neurol 422:159-171
29. Ashton JC, Zheng Y, Liu P et al (2004) Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation. Brain Res 1021:264-271
30. Roche R, Hoareau L, Bes-Houtmann S et al (2006) Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol 126:177-187
31. Van Sickle MD, Duncan M, Kingsley PJ et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329-332
32. Gong JP, Onaivi ES, Ishiguro H et al (2006) Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071:10-23
33. Dinh TP, Carpenter D, Leslie FM et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819-10824
34. Cravatt BF, Giang DK, Mayfield SP et al (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87
35. Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulie P, Piomelli D (2000) Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol 408:161-168
36. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R (2005) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27:73-100
37. Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590-594
38. Ravier MA, Guldenagel M, Charollais A et al (2005) Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 54:1798-1807
39. Singh V, Brendel MD, Zacharias S et al (2007) Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. J Clin Endocrinol Metab 92:673-680
40. Tabarin A, Diz-Chaves Y, Carmona M del C et al (2005) Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes 54:3510-3516
41. Cota D, Tschop MH, Horvath TL, Levine AS (2006) Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51:85-107